InvestorsHub Logo
Followers 17
Posts 987
Boards Moderated 0
Alias Born 01/24/2013

Re: Spebenz post# 80140

Wednesday, 12/03/2014 11:02:20 AM

Wednesday, December 03, 2014 11:02:20 AM

Post# of 403111
Thank you for sharing this. Seems to me that our secondary end points for K could make a compelling argument for just that but since CTIX is planning multiple phase 2/3 trials that we are embarking on, it is essentially the same thing as we could potentially end up with FDA approval for a single indication without an additional trial.

Exciting!!!

GO CTIX and Patient "X"!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News